Home Newsletters Cell Therapy News Genetic Ablation of PRDM1 in Antitumor T Cells Enhances Therapeutic Efficacy of...

Genetic Ablation of PRDM1 in Antitumor T Cells Enhances Therapeutic Efficacy of Adoptive Immunotherapy

0
Scientists identified PR domain zinc finger protein 1 (PRDM1) i.e., Blimp-1, as a key epigenetic gene associated with terminal T cell differentiation.
[Blood]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version